欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/1787/001
药品名称Rabeprazole KRKA 10 mg gastro-resistand tablets
活性成分
    • rabeprazole sodium salt 10.0 mg
剂型Gastro-resistant tablet
上市许可持有人Krka, d.d., Novo mesto Smarjeska cesta 6 8501 Novo mesto Slovenia
参考成员国 - 产品名称Netherlands (NL)
互认成员国 - 产品名称
    • Germany (DE)
      Rabeprazol Krka 10 mg magensaftresistente Tabletten
    • Austria (AT)
      Rabeprazol Krka 10 mg magensaftresistente Tabletten
    • Spain (ES)
    • Italy (IT)
    • Poland (PL)
      Zulbex
    • Latvia (LV)
    • Lithuania (LT)
      Zulbex 10mg skrandyje neirios tabletės
    • Estonia (EE)
    • Bulgaria (BG)
      Zulbex
    • Cyprus (CY)
      RABEPRAZOLE KRKA 10mg FC TABS
    • Czechia (CZ)
      Zulbex 10 mg gastro-resistant tablets
    • Romania (RO)
      Zulbex 10 mg comprimate gastrorezistente
    • Slovakia (SK)
      Zulbex10 mg gastroreizistentné tablety
    • Slovenia (SI)
      Zulbex 10 mg gastrorezistentne tablete
许可日期2010/07/02
最近更新日期2024/05/08
药物ATC编码
    • A02BC04 rabeprazole
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase